Dalrada Financial CORP

Dalrada Technology Group, Inc. has amended a previous SEC filing to correct the aggregate financial obligation for its subsidiary Genefic Inc. from $20 million to $25 million.

Dalrada Technology Group's subsidiary Genefic Inc. secured up to $25 million in financing through a standby letter of credit and accounts receivable facility, backed by the parent company's assets and an unlimited personal guarantee from CEO Brian Bonar.

Dalrada Technology Group's CEO outlines 2025 performance, operational progress in key markets, and strategic focus for 2026.

Dalrada Financial Corporation announced the immediate resignation of Chief Financial Officer Kyle McCollum, effective October 31, 2025.

Dalrada Financial Corporation's OTC Markets status changed to the Expert Market due to a delay in filing its annual report and a change in auditors.

Dalrada Financial Corporation will restate its financials for the period ended March 31, 2024, due to a $2.3 million revenue overstatement.

Dalrada Technology Group reports a significant net loss and negative working capital, raising substantial doubt about its ability to continue as a going concern, despite some segment revenue growth.

Dalrada Financial Corporation reported a net loss of $6.06 million for Q1 2026, a decrease in total revenues by 32%, and a significant increase in working capital deficit, alongside the resignation of its CFO.

Dalrada Financial Corporation reported a net loss of $4.2 million for Q3 2025, with significant working capital deficit and ongoing going concern doubts, despite revenue growth in its Climate Technology segment.

Dalrada Financial Corporation reported a substantial increase in net loss and a worsening working capital deficit for the six months ended December 31, 2024, raising significant doubt about its ability to continue as a going concern.

Dalrada Financial Corporation reported a significant increase in net loss and a worsening working capital deficit for the quarter ended September 30, 2024, raising substantial doubt about its ability to continue as a going concern, despite strong revenue growth in its Genefic healthcare division.

Dalrada Financial Corporation reported a significant decline in revenues and widening net losses for the quarter and nine months ended March 31, 2024, raising substantial doubt about its ability to continue as a going concern.

Dalrada Financial Corporation reports recurring losses and negative working capital, raising substantial doubt about its ability to continue as a going concern, despite some revenue growth in key segments.

Dalrada Financial Corporation reported a significant increase in net loss and a substantial decline in revenues across all its business segments for the fiscal year ended June 30, 2024, raising substantial doubt about its ability to continue as a going concern.

Dalrada Financial Corporation's 10-K filing reveals a year of strategic realignment, acquisitions, and financial challenges, including a net loss of $23.25 million.

Brian Bonar, CEO of Dalrada Financial Corp, recently acquired additional shares of the company's common stock through open market purchases.

Dalrada Financial Corp's CEO, Brian Bonar, has increased his holdings in the company through a series of open market purchases of common stock.

Dalrada Financial Corp's CEO, Brian Bonar, has increased his holdings in the company through a series of open market purchases of common stock.

Brian Bonar, CEO of Dalrada Financial Corp, has been actively purchasing shares of the company's common stock, increasing his direct holdings.

Brian Bonar, CEO of Dalrada Financial Corp, reports purchasing additional shares of the company's common stock.

CEO Brian Bonar reports several open market purchases of Dalrada Financial Corp (DFCO) common stock between April and June 2024, increasing his holdings.